Issue 59, 2016, Issue in Progress

A synthesized butyrolactone derivative in combination with chloroquine can inhibit cancer cell growth and lysosome vacuolation induced by chloroquine in A549 lung cancer cells

Abstract

3BDO in combination with chloroquine could elevate the Na+,K+-ATPase activity and decrease the expression of long non-coding RNA TGFB2-OT1. Therefore, the combination inhibited the cell growth and lysosomal vacuolation.

Graphical abstract: A synthesized butyrolactone derivative in combination with chloroquine can inhibit cancer cell growth and lysosome vacuolation induced by chloroquine in A549 lung cancer cells

Supplementary files

Article information

Article type
Communication
Submitted
28 Jan 2016
Accepted
23 May 2016
First published
30 May 2016

RSC Adv., 2016,6, 54099-54101

Author version available

A synthesized butyrolactone derivative in combination with chloroquine can inhibit cancer cell growth and lysosome vacuolation induced by chloroquine in A549 lung cancer cells

X. Chen, C. Fan, L. Su, B. Zhao and J. Miao, RSC Adv., 2016, 6, 54099 DOI: 10.1039/C6RA02533A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements